Carrier
Kaiser Permanente Hawaii
Its Marketplace formulary lists none of Wegovy, Zepbound, Foundayo or Saxenda; the Added Choice plan lists Wegovy and Zepbound with prior authorization.
Kaiser Permanente Hawaii publishes two lists that answer different questions. Its Marketplace formulary, effective October 1, 2026, is a closed list, and we didn't find Wegovy, Zepbound, Foundayo or Saxenda on it.
The Added Choice point-of-service formulary, run with Kaiser Permanente Insurance Company, is different: it lists Zepbound and Wegovy on tier 2 under "Weight Reduction", each with prior authorization and a quantity limit.
A drug that isn't on a closed list can still be requested, but only when formulary drugs have failed and the drug isn't excluded under your benefit.
Can you ask for a drug that isn't on the Marketplace list?
Your Kaiser doctor can ask for a non-formulary drug when the formulary options have failed and it's medically necessary. That route is closed if your benefit excludes the drug, and many plans exclude weight-loss drugs. Check your plan documents first.
Every claim above, with the document behind it
These are the policies we opened and the month we opened them. Each one carries its own policy number and effective date on its face, and those are printed here as the document shows them.
Read October 2026
"Our drug formulary is considered a closed formulary, which means that drugs on the list are usually covered under the prescription drug benefit, if you have one."
Kaiser Permanente Hawaii, Marketplace Drug Formulary (effective October 1, 2026), effective October 2026 · source
Non-formulary drugs: "your Kaiser Permanente doctor can request a non-formulary drug for you when formulary alternatives have failed and the non-formulary drug is medically necessary, provided the drug is not excluded under the prescription drug benefit."
Kaiser Permanente Hawaii, Marketplace Drug Formulary (effective October 1, 2026), effective October 2026 · source
We searched the Marketplace formulary for Wegovy, Zepbound, Foundayo and Saxenda and found none of them, while Ozempic appears on it. That's our reading of the document, not a statement Kaiser makes.
Kaiser Permanente Hawaii, Marketplace Drug Formulary (effective October 1, 2026) · source
Kaiser Hawaii's formulary directory links this same Marketplace formulary for both Small Employer Group plans (2–49 employees) and Large Employer Group plans (50 or more employees). The document's title alone does not limit it to individual Marketplace coverage.
Kaiser Permanente Hawaii, Drug formulary (covered drugs) · source
Read September 2026
The Added Choice formulary covers "our Added Choice Point-of-Service plan offered by Kaiser Permanente Insurance Company (KPIC) and Kaiser Foundation Health Plan, Inc." Under "Weight Reduction" it lists "ZEPBOUND SUBCUTANEOUS PEN" and "WEGOVY SUBCUTANEOUS PEN" on tier 2, each with PA and a quantity limit.
Kaiser Permanente Insurance Company, 2026 Added Choice Formulary with Specialty Drug Tier (Hawaii) · source
What these documents cannot tell you
Everything above is what Kaiser Permanente Hawaii publishes. None of it establishes what your own plan does, and the gap between those two things is wider than a carrier policy makes it look.
- Kaiser's directory identifies the Marketplace formulary for its small and large employer groups as well as individual plans. Added Choice uses its separate list. QUEST (Medicaid) and Medicare lists weren't checked.
- Being on a list isn't the same as being covered for weight loss. Your plan documents decide that.
- None of this is legal or medical advice. Your plan documents and your notice govern your case.
Where this comes from
Read October 2026 unless marked.
- Kaiser Permanente Hawaii, Marketplace Drug Formulary (effective October 1, 2026), effective October 2026 — Open the document
- Kaiser Permanente Insurance Company, 2026 Added Choice Formulary with Specialty Drug Tier (Hawaii) — Open the document (read September 2026)
- Kaiser Permanente Hawaii, Drug formulary (covered drugs) — Open the document
Where to go next
- Kaiser Permanente California's formularies
- How employer and commercial plans treat GLP-1s
- Which insurance plans cover Zepbound and Wegovy, carrier by carrier
- How to appeal a commercial or employer plan denial
- Every carrier we have read
American GLP is not a law firm, an insurer, a government office or a clinician, and nothing here is legal or medical advice. This page describes what Kaiser Permanente Hawaii publishes. It is not affiliated with Kaiser Foundation Health Plan, Inc. (Hawaii region) and Kaiser Permanente Insurance Company, and your own plan documents and your own notice govern your case. Policies carry effective dates and change — read the sources before you act.